Richard Whitley to Oseltamivir
This is a "connection" page, showing publications Richard Whitley has written about Oseltamivir.
Connection Strength
2.514
-
Oseltamivir for influenza - Authors' reply. Lancet. 2016 Jan 09; 387(10014):125.
Score: 0.550
-
Oseltamivir for influenza - Authors' reply. Lancet. 2015 Sep 19; 386(9999):1135-6.
Score: 0.538
-
Global assessment of resistance to neuraminidase inhibitors, 2008-2011: the Influenza Resistance Information Study (IRIS). Clin Infect Dis. 2013 May; 56(9):1197-205.
Score: 0.447
-
The role of oseltamivir in the treatment and prevention of influenza in children. Expert Opin Drug Metab Toxicol. 2007 Oct; 3(5):755-67.
Score: 0.310
-
Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet. 2015 May 02; 385(9979):1729-1737.
Score: 0.129
-
The posology of oseltamivir in infants with influenza infection using a population pharmacokinetic approach. Clin Pharmacol Ther. 2014 Sep; 96(3):380-9.
Score: 0.123
-
Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenza. J Infect Dis. 2013 Mar 01; 207(5):709-20.
Score: 0.111
-
Oseltamivir dosing for influenza infection in premature neonates. J Infect Dis. 2010 Aug 15; 202(4):563-6.
Score: 0.095
-
Safety of oseltamivir compared with the adamantanes in children less than 12 months of age. Pediatr Infect Dis J. 2010 Mar; 29(3):195-8.
Score: 0.092
-
Prevention and treatment of influenza in high-risk groups: children, pregnant women, immunocompromised hosts, and nursing home residents. J Infect Dis. 2006 Nov 01; 194 Suppl 2:S133-8.
Score: 0.073
-
Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J. 2001 Feb; 20(2):127-33.
Score: 0.049